SCHEMBL2256284

SCHEMBL2256284

Brc1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.71
MAPK1 P28482 2/20 0.71
NPC1 O15118 2/20 0.67
RAB9A P51151 2/20 0.67
NFKB1 P19838 1/20 0.67
NFKB2 Q00653 1/20 0.67
RELA Q04206 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
NR1H4 Q96RI1 1/20 0.62
NR1H2 P55055 4/20 0.58
NR1H3 Q13133 4/20 0.58
DGAT1 O75907 1/20 0.58
CYP1A1 P04798 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP1B1 Q16678 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
ABCG2 Q9UNQ0 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255716 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL19784904 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL17876525 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL2252359 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL29382228 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21385053 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21384241 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21849525 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL21382820 1.00 ALDH1A1 (0.71) ALDH1A1MAPK1NPC1RAB9ANFKB1
SCHEMBL2627622 0.98 ALDH1A1 (0.67) ALDH1A1MAPK1NPC1RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 US disclosed
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2023-06-13 US disclosed
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2023-06-13 US disclosed
EP-3858831-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT Materials Co., Ltd. (KR) 2021-08-04 EP disclosed
US-20210202863-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-07-01 US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 US disclosed
WO-2021079915-A1 TRIAZINE COMPOUND HAVING PYRIDYL GROUP AND PYRIDINE COMPOUND 東ソー株式会社 2021-04-29 WO disclosed
EP-1930329-B1 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT TOSOH CORP (JP) 2012-10-24 EP disclosed
US-7994316-B2 1,3,5-triazine derivative, production method thereof and organic electroluminescence device comprising this as a composing component TOSOH CORPORATION (JP) 2011-08-09 US disclosed
US-20090281311-A1 1,3,5-TRIAZINE DERIVATIVE, PRODUCTION METHOD THEREOF AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THIS AS A COMPOSING COMPONENT TOSOH CORPORATION (JP) 2009-11-12 US disclosed
EP-1930329-A1 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT Tosoh Corporation (JP) 2008-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210202863-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 ALDH1A1 15/4885MAPK1 581/4885NPC1 2476/4885
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 ALDH1A1 184/4885MAPK1 2766/4885NPC1 394/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 ALDH1A1 184/4885MAPK1 2766/4885NPC1 394/4885
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, CYP1A1 ALDH1A1 15/4885MAPK1 581/4885NPC1 2476/4885
US-20090281311-A1 1,3,5-TRIAZINE DERIVATIVE, PRODUCTION METHOD THEREOF AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THIS AS A COMPOSING COMPONENT KCNJ2, KCNA4, KCNJ4 ALDH1A1 699/4885MAPK1 1634/4885NPC1 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.